Nutritional management of chronic kidney disease

K Kalantar-Zadeh, D Fouque - New England Journal of Medicine, 2017 - Mass Medical Soc
Nutritional Management of Chronic Kidney Disease | NEJM Skip to main content NEJM Group
Follow Us Facebook Twitter Instagram YouTube LinkedIn Prepare to become a physician …

Hyperkalemia and hypokalemia in CKD: prevalence, risk factors, and clinical outcomes

S Gilligan, KL Raphael - Advances in chronic kidney disease, 2017 - Elsevier
Abnormalities of serum potassium are common in patients with CKD. Although hyperkalemia
is a well-recognized complication of CKD, the prevalence rates of hyperkalemia (14%-20%) …

Randomized trial on the effects of dietary potassium on blood pressure and serum potassium levels in adults with chronic kidney disease

S Turban, SP Juraschek, ER Miller III, CAM Anderson… - Nutrients, 2021 - mdpi.com
In the general population, an increased potassium (K) intake lowers blood pressure (BP).
The effects of K have not been well-studied in individuals with chronic kidney disease …

[HTML][HTML] Revisiting RAAS blockade in CKD with newer potassium-binding drugs

PI Georgianos, R Agarwal - Kidney international, 2018 - Elsevier
Among patients with proteinuric chronic kidney disease (CKD), current guideline
recommendations mandate the use of agents blocking the renin angiotensin aldosterone …

[HTML][HTML] Low serum potassium levels and clinical outcomes in peritoneal dialysis—international results from PDOPPS

SJ Davies, J Zhao, H Morgenstern, J Zee… - Kidney international …, 2021 - Elsevier
Introduction Hypokalemia, including normal range values< 4 mEq/l, has been associated
with increased peritonitis and mortality in patients with peritoneal dialysis. This study sought …

Hyperkalemia with RAAS inhibition: mechanism, clinical significance, and management

GL Hundemer, MM Sood - Pharmacological research, 2021 - Elsevier
Renin-angiotensin-aldosterone system (RAAS) inhibitors are evidence-based treatments for
a number of conditions including hypertension, diabetes mellitus, chronic kidney disease …

Machine learning algorithms identify hypokalaemia risk in people with hypertension in the United States National Health and Nutrition Examination Survey 1999–2018

Z Lin, YT Cheng, BMY Cheung - Annals of Medicine, 2023 - Taylor & Francis
Background Hypokalaemia is a side-effect of diuretics. We aimed to use machine learning to
identify features predicting hypokalaemia risk in hypertensive patients. Methods Participants …

Chronic hyperkaliemia in chronic kidney disease: an old concern with new answers

S Borrelli, I Matarazzo, E Lembo, L Peccarino… - International Journal of …, 2022 - mdpi.com
Increasing potassium intake ameliorates blood pressure (BP) and cardiovascular (CV)
prognoses in the general population; therefore the World Health Organization recommends …

Effects of calcium, magnesium, and potassium concentrations on ventricular repolarization in unselected individuals

R Noordam, WJ Young, R Salman, JK Kanters… - Journal of the American …, 2019 - jacc.org
Background: Subclinical changes on the electrocardiogram are risk factors for
cardiovascular mortality. Recognition and knowledge of electrolyte associations in cardiac …

Let them eat healthy: can emerging potassium binders help overcome dietary potassium restrictions in chronic kidney disease?

EJ Sussman, B Singh, D Clegg, BF Palmer… - Journal of Renal …, 2020 - Elsevier
Potassium-rich foods might provide many health benefits even to people who have declining
renal function. The barrier to obtaining these health benefits has long been the concern over …